Hepatitis Forums
Hepatitis C Main Forums => Hepatitis C and HIV Coinfection => Topic started by: Hep Editors on January 04, 2019, 10:40:03 am
-
Starting antiretroviral (ARV) treatment for HIV when CD4s are still high reduces the risk of liver fibrosis compared with waiting to start ARVs until the immune system has deteriorated somewhat, aidsmap reports. This holds true even among people without hepatitis B or C virus (HBV/HCV).
Publishing their findings in the journal Hepatology, researchers conducted an analysis from the global START trial, a randomized controlled study that enrolled people with HIV who had a CD4 count greater than 500 and randomized them to start ARVs immediately or wait until their CD4s had dropped below 350.
For more...
https://www.hepmag.com/article/treating-hiv-early-lowers-liver-fibrosis-risk